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VIEW AND REVIEW
Neurocysticercosis as a probable risk factor 
for hippocampal sclerosis
Neurocisticercose como provável fator de risco para esclerose hipocampal
Gagandeep Singh1,2, Josemir W. Sander2,3
Human brain infestation with the larval stage of the tape-
worm Taenia solium, known as neurocysticercosis (NCC), is 
endemic in many low-income countries but is also recog-
nized in high-income countries (e.g., the United States)1. It is 
estimated that between two and eight million people world-
wide have NCC2. Population studies in T. solium-endemic 
regions of South-Central America, India and parts of Africa 
have identified NCC as the putative risk factor in roughly one 
third of epilepsy cases3,4,5,6.
Seizures are the most common clinical presentation 
and are estimated to occur in up to 80% of people with 
symptomatic NCC7. Follow-up studies have suggested that 
the prognosis for seizure control is good overall, though 
seizures might recur on antiepileptic drug withdrawal8,9. 
Rarely, however, NCC might be associated with difficult-
to-treat epilepsy10,11,12,13. The substrates underlying chronic, 
often drug-resistant, epilepsy are a matter of considerable 
speculation as well as ongoing investigation. Perilesional 
gliosis, seen in unconventional magnetic resonance (MR) 
sequences (e.g., magnetization transfer imaging) but 
occult in routine MR sequences, has been associated with 
poorly-controlled epilepsy13,14. This, however, needs to be 
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ABSTRACT
Neurocysticercosis is one of the most common risk factors for epilepsy but its association with drug-resistant epilepsy remains uncertain. 
Conjectures of an association with drug-resistant epilepsy have been fueled by reports of an association between calcific neurocysticercosis 
lesions (CNL) and hippocampal sclerosis (HS) from specialized epilepsy centers in Taenia solium-endemic regions. The debate arising from 
these reports is whether the association is causal. Evidence for the association is not high quality but sufficiently persuasive to merit further 
investigation with longitudinal imaging studies in population-based samples from geographically-diverse regions. The other controversial 
point is the choice of a surgical approach for drug-resistant epilepsy associated with CNL-HS. Three approaches have been described: 
standard anteromesial temporal lobectomy, lesionectomy involving a CNL alone and lesionectomy with anteromesial temporal lobectomy 
(for dual pathology); reports of the latter two approaches are limited. Presurgical evaluation should consider possibilities of delineating the 
epileptogenic zone/s in accordance with all three approaches.
Keywords: Drug resistant epilepsy; neurocysticercosis; epilepsy.
RESUMO
A neurocisticercose é um dos mais comuns fatores de risco para a epilepsia, mas sua associação com a epilepsia resistente a medicamentos 
(DRE) permanece incerta. Conjecturas de uma associação com a DRE têm sido alimentadas por relatos de uma associação entre lesões 
de neurocisticercose calcária (CNL) e esclerose hipocampal (HS) de centros especializados em epilepsia em regiões endêmicas de Taenia 
solium. O debate que surge desses relatórios é se a associação é causal. Se bem as evidências para a associação não são de alta qualidade, 
são suficientemente persuasivas para merecer mais investigação com estudos longitudinais de imagens em amostras de base populacional 
de regiões geograficamente diversas. O outro ponto controverso é a escolha da abordagem cirúrgica para a DRE associada à CNL-HS. 
Três abordagens têm sido descritas: lobectomia temporal ântero-mesial padrão, lesionectomia envolvendo apenas CNL e lesionectomia 
com lobectomia temporal ântero-mesial (para patologia dupla); os relatórios das duas últimas abordagens são limitados. A avaliação 
pré-cirúrgica deve considerar as possibilidades de delinear a (s) zona (s) epileptogênica (s) de acordo com as três abordagens.
Palavras-chave: Epilepsia resistente a medicamentos; neurocisticercose; epilepsia. 
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corroborated in larger-scale studies. If confirmed, the find-
ing might be relevant to cases of apparent cryptogenic 
epilepsy with normal imaging in people with evidence of 
previous exposure to T. solium. An association between cal-
cified NCC lesion(s) (CNL) and mesial temporal lobe epi-
lepsy with hippocampal sclerosis (HS) has also been sug-
gested, although some believe it to be purely coincidental15. 
Conversely, the finding of an association between NCC and 
HS might have a biological basis and implications for the 
burden of surgically-remediable epilepsy, in endemic and 
nonendemic regions16,17. Two issues merit consideration: (1) 
is the association between NCC and HS tenable and, if so, is 
it causal?; and (2) could the association influence the choice 
of surgical approaches to anti-epileptic drug-resistant epi-
lepsy associated with CNL-HS? Here, we examine published 
data concerning the possible association between CNLs 
and HS to clarify these issues.
METHODS
Search strategy
We searched Pubmed, LILACS, CABI Abstracts and the 
databases of two epilepsy journals (Epilepsia and Epileptic 
Disorders) in September 2016 for published reports (includ-
ing abstracts) of cohort, case-control and cross-sectional 
studies and small series and one-off case reports of an asso-
ciation between NCC and HS. We used the search terms, 
“neurocysticercosis” OR “cysticercosis” AND “temporal lobe 
epilepsy” OR “mesial temporal sclerosis” OR “hippocampal 
sclerosis”. Reference lists of the retrieved articles were hand 
searched for further references. We reviewed abstracts pub-
lished in conference proceedings published in the two epi-
lepsy journals but were unable to obtain additional informa-
tion required from most authors.
Extracted information
We extracted information on: the age of epilepsy onset; 
presence of, and age at, antecedent events; gender; and 
distribution of spikes (bilateral vs. unilateral; tempo-
ral vs. extratemporal). In those who had surgery we also 
extracted information on histological characteristics of 
the excised hippocampi; and postsurgical seizure out-
come. Surgical approaches were classified as (i) tempo-
ral lobectomy (including standard anteromesial tempo-
ral lobectomy and selective amygdalohippocampectomy) 
alone; (ii) temporal lobectomy plus resection of a CNL (of 
which temporal lobectomy and resection of a temporal 
lobe CNL was a special subgroup); and (iii) resection of 
CNL alone. The number of subjects with Engel’s Class I 
outcome following surgery in each of the three groups of 
surgical approaches was noted18.
Analysis and statistics
Three analyses were undertaken: (i) comparison of the 
reported frequency of CNLs in samples of people with HS 
and other epilepsies or neurological disorders; (ii) differ-
ences in various demographic and electroclinical parameters 
including postsurgical seizure outcome between two groups 
(people with HS with CNLs and those with HS alone); and 
(iii) concordance between the laterality of HS and CNLs on 
imaging studies. 
RESULTS
Analysis of retrieved studies
The literature search produced 33 abstracts (Figure 1). 
Review of abstracts yielded five articles that were deemed 
not relevant to the topic, another five published reviews 
and two personal viewpoints/letters. Seven reports alluded 
to isolated cases or small case series10,12,19,20,21,22,23. Another 
two case reports, one describing a degenerating cysticer-
cus (hence not CNL) in the amygdala and another with a 
frontal CNL but not fulfilling criteria for drug-resistant 
epilepsy, were reviewed but not included24,25. Data for the 
formal analysis were extracted mainly from the remaining 
studies although isolated reports were examined as well. 
Many of the reports were from the same center and over-
lapped in time. It is possible that these reports (Table 1) 
partly covered the same set of subjects11,15,16,26,27,28,29,30. Hence, 
the most relevant or recent publications with the most pro-
tracted recruitment period from each center were included 
for analysis)11,27,28,29. 
Association between HS and calcification
In five hospital-based studies that reported the fraction 
of HS samples with CNLs, the proportion varied from 27% to 
52% (median: 37%)15,16,28,30,31. The proportion of CNLs in cor-
responding samples of epilepsies other than HS at the same 
centers was 6-15% (median: 14%)16,30,31.
Differences between HS with CNLs and HS alone: 
Demographic and electro-clinical features 
A small Indian observational study reported an older age 
at onset of epilepsy in people with HS with CNLs in compari-
son with HS alone but this finding was not replicated in the 
larger Brazilian study11,27 (Table 2). Likewise, two Brazilian 
groups compared gender distribution in people who had HS 
with CNLs, with HS alone27,30. One group consistently reported 
an excess of females in people who had HS with CNLs, but 
this was not corroborated by an observational study from a 
different center in the same Brazilian state15,16,27,30. 
Some have commented on the absence of an initial 
precipitating illness in people who had HS with CNLs12,16. 
Others have found a lower frequency of an initial precipi-
tating illness in people with HS with CNLs, compared with 
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those with HS alone11,29, a finding not corroborated by still 
others31. An Indian study noted that while roughly a fifth of 
individuals with HS with CNLs had childhood febrile sei-
zures, nearly another half reported afebrile seizures in the 
first decade of life29.
An earlier Brazilian study found no difference in the pro-
portion of those with unilateral versus bitemporal spikes but 
a subsequent re-analysis from the same center with more 
cases, as well as another Indian study, noted that the finding 
of bitemporal spikes correlated with the presence of CNL in 
individuals with HS15,29,32.
Number and laterality of CNL and HS
Within CNL-HS groups in published reports, the propor-
tion of solitary calcification varied from 25% to 67%11,28,29,30,31. 
The case series from India had the highest proportion of soli-
tary calcifications11,29. Overall, 21–83% of the calcifications 
(regardless of whether they were solitary or multiple)11,15,31 
and 85-100% of solitary calcifications11,28,29,30 were found 
exclusively ipsilateral to the diseased hippocampus. Four 
studies reported the lobar location of the CNLs and in these 
reports the frequency of ipsilateral temporal lobe CNLs var-
ied between 9% and 67%.11,15,28,31 In some cases, varying from 
3% to 33%, the CNL was located within or in close proximity 
to the hippocampus (Figure 2 a-d).11,12,15,28
Choice of surgical approach and postsurgical 
outcome 
One small report of four cases, on whom a standard 
temporal lobectomy was performed, reported seizure free-
dom in only one individual with CNL-HS.11 In comparison, 
an Engel Class I outcome was reported in nearly three quar-
ters of a cohort of 126 people on whom standard temporal 
lobectomy was performed27 (Table 3).  A lesionectomy alone 
was performed on seven people and postoperative seizure 
freedom documented in four.11,23 In one of these cases, who 
continued to have seizures after lesionectomy, the seizures 
were related to new parenchymal cysticerci emerging after 
surgery.24 Only three individuals with an extratemporal CNL 
and HS evaluated with invasive EEG were reported; all had 
seizure onsets from the CNL as well as the hippocampus and 
were seizure-free following standard temporal lobectomy 
Records identified through PubMed, 
LILACS and CABI search
(n = 22)
Additional records identified through
hand search of bibliographies of
re-trieved papers
(n = 11)
Records after duplicates removed
(n = 33)
Records screened
(n = 33)
Records nonrelevant to topic
(n = 5)
Full-text articles assessed
for eligibility
(n =  28 )
Excluded: Reviews, letter,
personal viewpoint, case
reports (not DRE or not CNL)
(n=9) 
Studies reviewed
(n = 19)
Excluded: Case reports
and small case series (n = 9)
Studies included in 
final analysis
(n = 10)
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Note: 1. Search terms: (“Neurocysticercosis”[Mesh] OR Cysticercosis[TW]) AND (“mesial temporal sclerosis”[TW] OR “hippocampal sclerosis”[TW]); 2. Refer to 
Table 1 for classification of the reports included in the review.
Figure 1. Study results.
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with lesionectomy (excision of the CNL).11,16 Lastly, a subset 
comprising people in whom the CNL was located within or 
in close proximity to the hippocampus, including the para-
hippocampal and fusiform gyri, the insula and the tempo-
ral pole (3–33% of all operated cases with HS and CNL) was 
put together11,12,15,20. All were seizure-free following temporal 
resections, which included the CNL.
DISCUSSION
Is there an association between NCC and HS?
A growing number of reports supports the plausibil-
ity of an association between NCC and HS10,11,15,16,19-29,31. The 
small numbers of participants in most studies, variations in 
methods used and outcomes assessments, however, limit 
the application of quantitative meta-analytic approaches to 
clarify the association. Additionally, the available reports are 
either retrospective or cross-sectional studies, mostly origi-
nating from specialized centers in São Paulo, Brazil, thereby 
introducing a potential referral bias, which could confound 
the interpretation16,30,31. Several studies have compared the 
frequency of CNLs on CT scans between groups with HS and 
other epilepsies16,30,31. One compared the frequency of CNLs 
in people with HS with those with headache30. The compar-
ator groups (i.e., epilepsies other than those with HS and 
headache) are not ideal as there are documented associa-
tions between CNLs and epilepsy and headache in T. solium 
cysticercosis-endemic areas33,34. It might be pertinent to 
compare the frequency of CNLs in mesial temporal lobe epi-
lepsy associated with HS with other temporal lobe epilepsies 
and extratemporal lobe epilepsies but this does not seem to 
Table 1. Classification of published reports [excluding case reports and small (n = < 5) series] retrieved for this review.
Variable Author, year Study design Study location Comment
Studies of association 
between HS and CNL
Velasco et al., 200616 Hospital-based cross-sectional study
Sao Paulo, Brazil, 
Referral centre for 
epilepsy surgery
Compared prevalence of CNLs 
among patients with HS with 
other etiologies of epilepsy 
Oliveira et al., 201431 Hospital-based cross-sectional study
Sao Paulo, Epilepsy 
clinic-based
Compared prevalence of CNLs 
among patients with HS with 
other etiologies of epilepsy 
Taveira et al., 201530 Case control study, hospital-based
Sao Paulo, Referral 
centre for epilepsy 
surgery
Compared prevalence of CNLs 
among s patients with HS with 
other etiologies of epilepsy 
Del Brutto et al., 201535 Population-based, 
exposed-unexposed 
study
Ecuador
Determined prevalence ratio of 
hippocampal atrophy among 
patients with CNLs with those 
with no evidence of NCC
Del Brutto et al., 201736
Studies comparing 
demographic features 
of CNL-HS with HS 
alone
*Bianchin et al., 201528
Hospital-based series Sao Paulo, Brazil  Bianchin et al., 201327
Leite et al., 200015
Rathore et al., 201229
Hospital-based series Trivandrum, India  
Rathore et al., 201311
Studies describing 
surgical outcome in 
CNL-HS/CNL alone
Bianchin et al., 201327
Hospital-based series Sao Paulo, Brazil  
Leite et al., 200015
Rathore et al., 201311 Hospital-based series Trivandrum, India  
*The studies listed in this cell were published at different periods of time from the same center and comprised overlapping sets of cases. Hence, the latest 
reports with the largest number27,28 were used for analysis. Case reports and small series of cases are not represented in this table.
Table 2. Comparison of demographic and electroclinical 
features of CNL-HS and HS alone.
Author, year HS alone CNL-HS
Age of onset (First unprovoked seizure) (mean SD)
Rathore et al., 201229 10 ± 6 years 16 ± 7 years
Bianchin et al., 201327 9 ± 9 years 10 ± 8 years
Gender distribution (Proportion of femal.es)
Bianchin et al., 201327 54% 62%
Oliveira et al., 201531 70% 67%
Antecedent febrile seizures (initial. precipitating illness) 
{Proportion; (%)}
Chandra et al., 201012   Nil
Rathore et al., 201229 53% 22%
Oliveira et al., 201531 23% 27%
Proportion of bitemporal. spikes(%)
Leite et al., 200015 10% 11%
Rathore et al., 201229 8% 50%
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Figure 2. Hippocampal sclerosis with a spatially-proximated CNL. Note (a) T2 oblique coronal image showing left HS, (b) T1 
oblique coronal image demonstrating left hippocampal atrophy, (c) T2 oblique coronal image showing proximate CNL (arrow) 
with surrounding hyperintensity presumed to be gliosis and (d) axial computed tomography image clearly demonstrating the left 
temporal CNL.
Table 3. Surgical procedures and outcomes following surgery for drug-resistant epilepsy in people with CNLs with or without HS.
Surgical procedure Reference (Author, year) Number of cases operated on
Number of cases with 
postoperative seizure 
freedom
Standard anteromesial temporal 
lobectomy (with/without CNL in the 
surgical field)
Rathore et al., 201311 7 4 (57%)
Leite et al., 200015 32 26 (81%)
Bianchin et al., 201327 126 94 (75%)
Lesionectomy alone
Ooi et al., 201123 1 0
Rathore et al., 201311 6# 4
Anteromesial temporal lobectomy with 
resection of extratemporal CNL Rathore et al., 2013
11 2 2
Including one case with HS and five with no imaging evidence of HS (Ref. 11).
A B
C D
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have been undertaken. The association should also be exam-
ined in a population-based sample, a major undertaking in 
resource-limited settings. A single, small population-based 
survey in Ecuador evaluated the association between CNLs 
and hippocampal atrophy, suggesting that CNLs or their 
precursors, i.e., active NCC or associated seizures, might be 
causally associated with hippocampal injury35. The majority 
of participants, however, did not have epilepsy, a defining fea-
ture of HS. When stratified according to age, the association 
became significant only in those aged above 68 years36. This 
age-specific association is in marked contrast to the usual 
much younger age of onset of typical HS37-39. Sclerosis of the 
hippocampus on T2 or FLAIR MR images, crucial to the rec-
ognition of HS, was also not reported.
Demographic and electroclinical characteristics of 
CNL-HS
It might be argued that, if indeed there were a causal asso-
ciation between CNLs and HS, the CNLs might modify some 
of the demographic, electroclinical and prognostic character-
istics of HS. Among various demographic attributes, a gender 
predilection has been reported from a single Brazilian cen-
ter with an excess of women among people with CNL-HS15,26. 
Gender-related differences in host inflammatory responses 
to cysticerci have been suggested as the basis for this obser-
vation.40 The findings of a gender predilection have not been 
replicated in a report from a different center in Brazil, nor 
in India29,31. There is also no documented gender predilection 
for HS alone as no differences have been reported in large 
HS series37,38,39. Other demographic features, e.g., age of onset 
of habitual seizures, in CNL-HS appear to be similar to HS 
alone, usually in the first two decades of life. Some reports 
also covered the frequency of an antecedent initial precipi-
tating illness in people with CNL-HS11,12,16,29. Febrile seizures 
have been reported in 82% of people with HS alone37,39, while 
antecedent, early life afebrile seizures are extremely rare. 
There have been reports of a lower frequency, or even com-
plete absence, of antecedent febrile seizures in people with 
CNL-HS12,29,32. Conversely, afebrile seizures in the first decade 
of life, reported with a high frequency (44%) in people with 
CNL-HS from India may represent acute seizures related to 
active parenchymal NCC29. It is also possible that the lower 
frequencies of febrile seizures may partly be accounted for by 
a recall bias. More studies from different geographical loca-
tions are clearly desirable to clarify the gender predilection as 
well as other possible distinctive features of CNL-HS, if any.
Location and laterality of CNLs in relation to HS
We surmise that causality is more likely if the CNL is 
located ipsilateral to the side of HS and within the ipsilateral 
hemisphere, in proximity to the hippocampus. The likelihood 
of publication bias should be taken in to account in inter-
preting published data regarding the location of the CNLs. 
Besides, the analysis of the laterality and location of CNLs in 
relation to HS is complicated by the multiplicity of CNLs with 
distribution across both hemispheres, making it difficult to 
decide which of the lesions is the culprit; in some reports a 
large proportion of the CNLs are multiple.15,28 In comparison, 
a solitary CNL offers the opportunity of analyzing the lateral-
ity and lobar (or sublobar) location of the CNL in relation to 
the HS. Overall, the majority (roughly three quarters) of the 
reported solitary CNLs are located ipsilateral to the HS.11,15,28,31 
In a number of isolated case reports and in some of the larger 
series, the CNL may be located within, or in close proxim-
ity to, the hippocampus followed by the ipsilateral temporal 
lobe.11,12,15,20 This seems to suggest that the proximity of the 
CNL to the hippocampus and related structures might be a 
factor in the development of HS. It is plausible that an inflam-
matory response to the CNL engenders an insult to the proxi-
mate hippocampus, thereby provoking a cascade of events 
eventually leading to the development of HS.
Is the association causal?
Even as an association between NCC and HS is plausible, 
we need to consider whether the association is causal.41 To 
infer causality, more studies in different geographic regions, 
endemic and nonendemic, are required to gauge the strength 
and consistency of the association. Support for a biological 
gradient in the association is provided by the predilection of 
solitary CNLs distributed ipsilaterally and within the same 
hemisphere, in proximate locations to the diseased hippo-
campus. These findings may be implicit with the argument 
that acutely degenerating cysticercus or associated seizures 
might constitute the initial precipitating illness for HS. It 
is also desirable to conduct experiments in animal models 
with, for example, cysticercus extracts injected into different 
locations in the cerebral hemispheres, to determine the effect 
on hippocampal structure and function.42
Choice of surgical approach
An assessment of seizure outcome following surgery 
is precluded by the limited number of reports, varied use 
of presurgical evaluation strategies and time periods and 
methods of outcome assessment. It appears, however, that 
surgical outcome following standard temporal lobe pro-
cedures in terms of seizure freedom in CNL-HS is similar 
to HS alone.15,16,27 Surgical failure with standard anterome-
sial temporal lobectomy following noninvasive presurgi-
cal workup has also been anecdotally documented, imply-
ing that no one-fits-all approach can be recommended.11 
Other approaches, including lesionectomy (removal of 
CNL alone) and combined approaches (i.e., lesionectomy 
in addition to the temporal lobectomy; cf, dual pathology) 
have been employed in the surgical management of drug-
resistant epilepsy associated with CNL-HS.11 It is reason-
able to recommend that the surgical approach should 
be tailored to the situation and the results of presurgical 
workup. If dual pathology, in terms of independent seizure 
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origins from the hippocampus and CNL, is suspected dur-
ing noninvasive presurgical workup, then recourse to inva-
sive monitoring appears appropriate and justified despite 
limitations of cost and availability in regions where NCC 
is endemic. In situations where the CNL is located close 
to the hippocampal structures, it is reasonable to excise 
the lesion along with other temporal lobe structures. Since 
different clinical scenarios exist, a case-by-case approach 
should be followed in evaluating and managing people 
with CNL-HS. Indeed, the categorization of CNLs in asso-
ciation with HS described in a recent review compliments 
the approach presented here.43
Future directions
If CNLs and HS were causally associated, the underlying 
basis might be an interaction between the cysticercus gran-
uloma and the hippocampus structure and function or an 
effect mediated through kindling by repeated seizures. The 
fact that CNLs can be found on imaging studies in as many 
as 10–18% of asymptomatic individuals in T. solium-endemic 
communities44,45 might be utilized in dissecting out a direct 
effect of cysticercus granulomas versus an effect mediated 
through seizures, and it might be worthwhile to study the 
prevalence of hippocampal abnormalities in people with 
asymptomatic CNLs. 
The association between NCC and HS merits further 
investigation as it has far-reaching implications for under-
standing not only the burden and etiology of epilepsies in 
resource-poor countries but also, overall, the phenomenon 
of epileptogenesis. 
CONCLUSIONS
The available evidence is at best hypothesis-generating, 
providing preliminary support for an association between 
CNLs and HS. The association should be investigated fur-
ther in population-based samples to avoid selection bias. 
Prospective, longitudinal follow-up imaging studies of the 
hippocampal structure and volume in people presenting 
with a first seizure associated with NCC are desirable. The 
longitudinal design would help in establishing temporal-
ity between cause (NCC infestation) and effect (HS). Future 
studies should also be located in geographically disparate T. 
solium-endemic regions. 
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